Examines anticancer effects of Ziziphus nummularia gold nanoparticles in TNBC, indicating potential for new treatment strategies.
Triple-negative breast cancer (TNBC) remains one of the most aggressive breast cancer subtypes with limited targeted therapeutic options, highlighting the need for innovative, biocompatible treatment strategies. Plant-mediated green synthesis offers a sustainable route for gold nanoparticle (AuNP) fabrication with enhanced biological functionality. In this study, Ziziphus nummularia ethanolic extract (ZNE) was employed as a reducing and capping agent to synthesize stable, crystalline, and predominantly spherical gold nanoparticles (ZNE-AuNPs). Comprehensive physicochemical characterization confirmed successful nanoparticle formation and phytochemical capping. Importantly, this work provides novel biological and mechanistic insights into the anticancer effects of ZNE-AuNPs specifically in TNBC. ZNE-AuNPs exhibited notable antioxidant activity and significantly reduced the viability of MDA-MB-231 TNBC cells in a concentration- and time-dependent manner. For the first time, the anticancer activity of ZNE-AuNPs in TNBC was mechanistically linked to the suppression of cellular proliferation (decreased Ki-67), induction of apoptosis (modulation of BAX, BCL-2, and caspase-3), and inhibition of ERK phosphorylation, implicating the MAPK/ERK signaling pathway. Taken together, these findings support Ziziphus nummularia-derived AuNPs as a sustainable nanotherapeutic platform and establish their previously unexplored mechanistic relevance in TNBC.
No takes yet. Share an insight, caveat, or question.
Abdallah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: